🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study to investigate the efficacy and safety of an infusion of IO...
Status
Recruiting
Location
The Angeles Clinic and Research Institute
Start Date
2022-07-20
Trial ID
NCT05361174
Treatments Being Tested
This study will evaluate the safety of PD-1 knockout engineered T cells in ...
Status
Completed
Location
West China Hospital, Sichuan University
Start Date
2016-08-26
Trial ID
NCT02793856
Treatments Being Tested
This study will evaluate the safety of PD-1 knockout engineered T cells in ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT02867332
Treatments Being Tested
This study will evaluate the safety and effect of transcatheter arterial ch...
Status
Unknown
Location
The 3rd Xiangya Hospital of Central South University
Start Date
2019-06-20
Trial ID
NCT04417764
Treatments Being Tested
This study will evaluate the safety of PD-1 knockout engineered T cells in ...
Status
Withdrawn
Location
Department of Urology Peking University First Hospital
Start Date
2016-11
Trial ID
NCT02867345
Treatments Being Tested
The study is to assess the safety and efficacy of the anti-MUC1 CAR T cells...
Status
Unknown
Location
First Affiliated Hospital of Guangdong Pharmaceutical University
Start Date
2018-02-01
Trial ID
NCT03525782
Treatments Being Tested
Tumor infiltration lymphocytes (TILs) have been harvested from advanced can...
Status
Recruiting
Location
Second Affiliated Hospital of Guangzhou Medical University
Start Date
2021-01-01
Trial ID
NCT04842812
This study will evaluate the safety of PD-1 knockout engineered T cells in ...
Status
Withdrawn
Location
Department of Urology Peking University First Hospital
Start Date
2016-09
Trial ID
NCT02863913
Treatments Being Tested
The goal of this Phase I/II observational and interventional platform study...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-01
Trial ID
NCT07307053
This is an open label, single-site, dose-escalation study in up to 25 parti...
Status
Completed
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2020-03-13
Trial ID
NCT04213469
Treatments Being Tested